MicroPort® Hosts 2017 Coronary Product Distributor Conference

Shanghai, China – On May 23, the 2017 Annual Coronary Product Distributor Conference was held in Shanghai headquarters of Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") and about 200 people from 110 distributors all over China attended the meeting. Bo Peng, Chief Marketing Officer of MicroPort®, Dr. Qiyi Luo, Chief Technology Officer of MicroPort®, and senior management of MicroPort® Coronary Department attended the meeting.
During the meeting, Bo Peng delivered a speech in which he pointed out that we should follow the tendency and change accordingly. Afterwards, Dr. Qiyi Luo introduced MicroPort®'s innovative products under development, which attracted great interest from the distributors. Meanwhile, a special discussion panel about the implementation of China's "Two Invoice System" was held during the conference. Zhigang Zhang, Director of Marketing of China Medical Instrument (Group) Co., Ltd, Kun Cao, President of Shanghai Innostic Supply Chain Management Co., Ltd, Chuan Zhang, General Manager of Beijing Jiashi Weizhong Medical Device Co., Ltd, Bing Liu, General Manager of GKHT Medical Technology Co., Ltd, and Keda Xu, Vice President and Chief Operation Officer of Cardinal Health Shanghai Co., Ltd, were invited to express their own opinions regarding the challenges and opportunities the "Two Invoice System" may bring to the pharmaceutical industry and possible actions for pharma companies to consider.
During the dinner party on the same day, MicroPort® gave out several awards to 11 of its distributors, including Most Valuable Diamond Partner of the Year, Most Valuable Platinum Partner of the Year, Most Valuable Gold Partner of the Year, Partner of the Best Diversification of the Year, and etc.
During May 22, MicroPort® also hosted an outing activity with 60 distributors in attendance to enhance communications and strengthen friendship with them.
Lei Jiang, First Vice President of Domestic Coronary Sales & Marketing, said :" The year 2017 marks a crucial year for the development of China's medical device industry. We believe that there are boundless opportunities and there are also challenges we must strive to overcome. We are looking forward to working more closely with our distributors and build an even more successful future together."